Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP624670.RAHlp3fyKeqMVICbY6yy2STMeSiZeLKd8g9iLy7LVXAHY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP624670.RAHlp3fyKeqMVICbY6yy2STMeSiZeLKd8g9iLy7LVXAHY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP624670.RAHlp3fyKeqMVICbY6yy2STMeSiZeLKd8g9iLy7LVXAHY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP624670.RAHlp3fyKeqMVICbY6yy2STMeSiZeLKd8g9iLy7LVXAHY130_provenance.
- NP624670.RAHlp3fyKeqMVICbY6yy2STMeSiZeLKd8g9iLy7LVXAHY130_assertion description "[The relationship between 5-FU and gemcitabine sensitivity and the mRNA levels of human equilibrative nucleoside transporter 1 (hENT1), thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPD) was investigated using seven types of human pancreatic carcinoma cell line (AsPC1, BxPC3, MiaPaCa-2, PSN1, Panc1, PCI6, and KMP-4).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624670.RAHlp3fyKeqMVICbY6yy2STMeSiZeLKd8g9iLy7LVXAHY130_provenance.
- NP624670.RAHlp3fyKeqMVICbY6yy2STMeSiZeLKd8g9iLy7LVXAHY130_assertion evidence source_evidence_literature NP624670.RAHlp3fyKeqMVICbY6yy2STMeSiZeLKd8g9iLy7LVXAHY130_provenance.
- NP624670.RAHlp3fyKeqMVICbY6yy2STMeSiZeLKd8g9iLy7LVXAHY130_assertion SIO_000772 17695509 NP624670.RAHlp3fyKeqMVICbY6yy2STMeSiZeLKd8g9iLy7LVXAHY130_provenance.
- NP624670.RAHlp3fyKeqMVICbY6yy2STMeSiZeLKd8g9iLy7LVXAHY130_assertion wasDerivedFrom befree-2016 NP624670.RAHlp3fyKeqMVICbY6yy2STMeSiZeLKd8g9iLy7LVXAHY130_provenance.
- NP624670.RAHlp3fyKeqMVICbY6yy2STMeSiZeLKd8g9iLy7LVXAHY130_assertion wasGeneratedBy ECO_0000203 NP624670.RAHlp3fyKeqMVICbY6yy2STMeSiZeLKd8g9iLy7LVXAHY130_provenance.
- befree-2016 importedOn "2016-02-19" NP624670.RAHlp3fyKeqMVICbY6yy2STMeSiZeLKd8g9iLy7LVXAHY130_provenance.